Skip to main content
Clinical Trials/ChiCTR-OOC-16008695
ChiCTR-OOC-16008695Active, not recruitingNot Applicable

老年弥漫大 B 细胞淋巴瘤患者应用综合老年评估(CGA)指导治疗决策的前瞻性观察研究

自筹4 sites in 1 country93 target enrollmentStarted: June 21, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
93
Locations
4
Primary Endpoint
总生存时间(OS)

Study Overview

Brief Summary

评价在老年弥漫大 B 细胞淋巴瘤患者中综合老年评估(CGA)指导治疗决策的有效性和安全性

Study Design

Study Type
观察性研究
Primary Purpose
单臂

Eligibility Criteria

Ages
65 to — (—)
Sex
All

Inclusion Criteria

  • 年龄≥65 岁;经病理组织学及免疫组织化学确诊的 DLBCL 患者;签署知情同意书自愿参加本观察性研究者。

Exclusion Criteria

  • 既往有血液肿瘤或实体瘤病史行放化疗者;中枢神经系统或脑膜受累患者;HIV 感染者。

Arms & Interventions

人群

Outcomes

Primary Outcomes

总生存时间(OS)

无进展生存(PFS)

Secondary Outcomes

  • 总有效率(ORR)
  • 3-4 度毒性反应

Investigators

Sponsor
自筹

Study Sites (4)

Loading locations...

Similar Trials